Durvalumab Climbs the MATTERHORN of Gastric Cancer
Durvalumab added to chemotherapy improves pathological complete response rate in the perioperative setting for patients with gastric cancer. Perioperative FLOT ...
© Doctors News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.